Silver Coast Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$556K Buy
2,210
+161
+8% +$34.6K 0.17% 64
2026
Q1
$446K Buy
2,049
+165
+9% +$36.6K 0.14% 67
2025
Q4
$430K Sell
1,884
-58
-3% -$13.2K 0.15% 62
2025
Q3
$450K Sell
1,942
-352
-15% -$71.7K 0.15% 59
2025
Q2
$426K Buy
2,294
+394
+21% +$73.2K 0.15% 58
2025
Q1
$398K Sell
1,900
-348
-15% -$67.7K 0.15% 57
2024
Q4
$399K Buy
2,248
+42
+2% +$7.72K 0.15% 57
2024
Q3
$436K Sell
2,206
-162
-7% -$30.2K 0.16% 52
2024
Q2
$406K Buy
2,368
+540
+30% +$89.5K 0.17% 52
2024
Q1
$333K Sell
1,828
-61
-3% -$10.5K 0.14% 58
2023
Q4
$293K Buy
+1,889
New +$275K 0.13% 53

Other funds holding ABBV

Silver Coast Investments's ABBV Position: Q2 2026 in Review

Silver Coast Investments increased its AbbVie (ABBV) stake by 7.9% in Q2 2026, buying an estimated $34.6K and bringing the position to 2,210 shares worth $556K. The position accounts for 0.17% of the portfolio, ranked #64.

Silver Coast Investments first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,417 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Silver Coast Investments held 2,210 shares of AbbVie worth $556K as of Q2 2026.
  • Silver Coast Investments bought 161 AbbVie shares in Q2 2026, an estimated $34.6K.
  • AbbVie made up 0.17% of Silver Coast Investments's portfolio in Q2 2026, its #64 holding.
  • Silver Coast Investments first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 2,417 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Silver Coast Investments's 13F filing for Q2 2026, filed 24 Jul 2026.